Advice
NICE is unable to make a recommendation about the use in the NHS of slow-release potassium bicarbonate–potassium citrate for treating distal renal tubular acidosis. This is because Advicenne considers that, at this time, there is not enough evidence to provide a submission for this appraisal.
Information
If NHS organisations wish to consider potassium bicarbonate–potassium citrate for this indication, they should follow the advice on rational local decision making in the NHS Constitution for England and the NHS Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012. This outlines the approach that should be taken when there is no NICE guidance.
NICE will review the position if the company decides that it wants to make an evidence submission.
ISBN: 978-1-4731-4812-3